WO2004053068A3 - Protein modification and maintenance molecules - Google Patents

Protein modification and maintenance molecules Download PDF

Info

Publication number
WO2004053068A3
WO2004053068A3 PCT/US2003/038573 US0338573W WO2004053068A3 WO 2004053068 A3 WO2004053068 A3 WO 2004053068A3 US 0338573 W US0338573 W US 0338573W WO 2004053068 A3 WO2004053068 A3 WO 2004053068A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein modification
pmmm
maintenance molecules
molecules
maintenance
Prior art date
Application number
PCT/US2003/038573
Other languages
French (fr)
Other versions
WO2004053068A2 (en
Inventor
Shanya D Becha
April J A Hafalia
Anita Swarnakar
Jayalaxmi Ramkumar
Thomas W Richardson
Amy E Kable
Joseph P Marquis
Reena Khare
Soo Yeun Lee
Uyen K Tran
Umesh G Bhatia
John D Burrill
Julie J Blake
Anne Ho
Wenjin Zheng
Jing Gao
Narinder K Chawla
Patricia M Mason
Pei Jin
Sally Lee
Original Assignee
Incyte Corp
Shanya D Becha
April J A Hafalia
Anita Swarnakar
Jayalaxmi Ramkumar
Thomas W Richardson
Amy E Kable
Joseph P Marquis
Reena Khare
Soo Yeun Lee
Uyen K Tran
Umesh G Bhatia
John D Burrill
Julie J Blake
Anne Ho
Wenjin Zheng
Jing Gao
Narinder K Chawla
Patricia M Mason
Pei Jin
Sally Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Shanya D Becha, April J A Hafalia, Anita Swarnakar, Jayalaxmi Ramkumar, Thomas W Richardson, Amy E Kable, Joseph P Marquis, Reena Khare, Soo Yeun Lee, Uyen K Tran, Umesh G Bhatia, John D Burrill, Julie J Blake, Anne Ho, Wenjin Zheng, Jing Gao, Narinder K Chawla, Patricia M Mason, Pei Jin, Sally Lee filed Critical Incyte Corp
Priority to AU2003300815A priority Critical patent/AU2003300815A1/en
Publication of WO2004053068A2 publication Critical patent/WO2004053068A2/en
Publication of WO2004053068A3 publication Critical patent/WO2004053068A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

Various embodiments of the invention provide human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.
PCT/US2003/038573 2002-12-05 2003-12-03 Protein modification and maintenance molecules WO2004053068A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003300815A AU2003300815A1 (en) 2002-12-05 2003-12-03 Protein modification and maintenance molecules

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US43163902P 2002-12-05 2002-12-05
US60/431,639 2002-12-05
US43431502P 2002-12-17 2002-12-17
US60/434,315 2002-12-17
US44244203P 2003-01-24 2003-01-24
US60/442,442 2003-01-24
US44414103P 2003-01-30 2003-01-30
US60/444,141 2003-01-30
US44949103P 2003-02-21 2003-02-21
US60/449,491 2003-02-21

Publications (2)

Publication Number Publication Date
WO2004053068A2 WO2004053068A2 (en) 2004-06-24
WO2004053068A3 true WO2004053068A3 (en) 2005-04-21

Family

ID=32512689

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/038573 WO2004053068A2 (en) 2002-12-05 2003-12-03 Protein modification and maintenance molecules

Country Status (2)

Country Link
AU (1) AU2003300815A1 (en)
WO (1) WO2004053068A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005090569A1 (en) * 2004-03-24 2005-09-29 The Council Of The Queensland Institute Of Medical Research Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
JP2008522632A (en) 2004-12-13 2008-07-03 アレシア・バイオセラピューティクス・インコーポレーテッド Polynucleotide and polypeptide sequences involved in the process of bone remodeling
EP2035574A1 (en) * 2006-06-17 2009-03-18 Bayer HealthCare AG Use of n-acylaminoacylpeptide hydrolase (apeh) as a therapeutic or diagnostic target
JP2010507387A (en) 2006-10-25 2010-03-11 クアーク・ファーマスーティカルス、インコーポレイテッド Novel siRNA and method of using the same
EP3472201A4 (en) 2016-06-20 2020-05-13 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
WO2017223117A1 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for diagnosis and treatment of autoimmune diseases
AU2017359450A1 (en) 2016-11-09 2019-05-30 HealthTell, Inc. Coatings with tunable amine density
CN110168370A (en) 2016-11-11 2019-08-23 健康之语公司 Method for identifying candidate biomarker
JP2020524275A (en) * 2017-06-19 2020-08-13 ヘルステル・インコーポレイテッドＨｅａｌｔｈｔｅｌｌ Ｉｎｃ． Immune signatures for differential diagnosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEW A. ET AL.: "Cloning, expression and chromosomal assignment of the human mitochondrial intermediate peptidase gene (MIPEP)", GENOMICS, vol. 40, 1997, pages 493 - 496, XP004459325 *
DATABASE PROTEIN [online] 15 August 2002 (2002-08-15), GISH K.C. ET AL., XP002985508, Database accession no. (ABG61880) *
DATABASE PROTEIN [online] 15 July 1999 (1999-07-15), CHEW A. ET AL., XP002985512, Database accession no. Q99797 *
DATABASE PROTEIN [online] December 2001 (2001-12-01), STRAUSBERG R., XP002985511, Database accession no. Q96G65 *
DATABASE PROTEIN [online] September 1993 (1993-09-01), ISAYA G. ET AL., XP002985510, Database accession no. A46273 *
ISAYA G. ET AL.: "Sequence analysis of rat mitochondrial intermediate peptidase: Similarity to zinc metallopeptidases and to a putative yeast homologue", PROC. NATL. ACAD. SCI. USA, vol. 189, September 1992 (1992-09-01), pages 8317 - 8321, XP002985509 *

Also Published As

Publication number Publication date
AU2003300815A8 (en) 2004-06-30
AU2003300815A1 (en) 2004-06-30
WO2004053068A2 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
WO2002046383A3 (en) Protein modification and maintenance molecules
WO2000070049A3 (en) Extracellular signaling molecules
WO2003052075A3 (en) Enzymes
WO2002063005A3 (en) Lipid-associated molecules
WO2003000844A3 (en) Protein modification and maintenance molecules
WO2002002603A3 (en) Protein modification and maintenance molecules
WO2003042357A3 (en) Enzymes
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2004009797A3 (en) Protein modification and maintenance molecules
WO2004053068A3 (en) Protein modification and maintenance molecules
WO2002060942A3 (en) Protein modification and maintenance molecules
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2003031568A3 (en) Intracellular signaling molecules
WO2001032888A3 (en) Human transferase molecules
WO2004044165A3 (en) Lipid-associated proteins
WO1999041373A3 (en) Human transport-associated molecules
WO2003031939A3 (en) Protein modification and maintenance molecules
WO2002101008A3 (en) Intracellular signaling molecules
WO2003100016A3 (en) Protein modification and maintenance molecules
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2004003162A3 (en) Enzymes
WO2003083084A3 (en) Protein modification and maintenance molecules
WO2003072729A3 (en) Enzymes
WO2003083082A3 (en) Enzymes
WO2003093439A3 (en) Enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP